Efficacy of sorafenib combined with transarterial chemoembolization in the treatment of advanced hepatocellular carcinoma: A meta-analysis

Figure 1  Study selection flow diagram for the meta-analysis.

Figure 2  Risk of bias evaluation for included studies, depicted with red indicating high risk and green indicating low risk.

Figure 3  Forest plot showing the impact of combining sorafenib with transarterial chemoembolization on overall survival.

Figure 4  Forest plot displaying the benefits of sorafenib and transarterial chemoembolization combination on progression-free survival.

Figure 5 Sensitivity analysis graphs confirming the stability of the meta-analysis results for overall survival and progression-free survival. A: Overall survival; B: Progression-free survival.

Figure 6  Funnel plot for evaluation of publication bias in the meta-analysis.